Pando Bioscience

Winter 2023 · Active

Gen-AI Designed Enzymes for Pharmaceutical Innovation

Location: Boston, US

Founded: 2022

Team size: 5

Industries:

About

Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.

Founders

Will CaoFounder
Will Cao is the co-founder and CEO of Pando Bioscience. During her Ph.D., Will changed her major from engineering machines to engineering bacteria (yes, making genetic modifications to bacteria, so they can produce things that they can't before). She has published first-author papers in Cell and Nature Biotechnology. In her spare time, she is a personal trainer and a kayak and scuba diving enthusiast.
LinkedIn Twitter
Yang WangFounder
Yang is the co-founder and CTO of Pando Bioscience. Experienced in enzyme science, bioinformatics, machine learning, systems biology, genetics and high-throughput automation. Worked at Ginkgo Bioworks for three years and routinely discovered/designed enzymes with tens-to-thousands-fold improvements. Trained at Dana-Farber Cancer Institute and deeply studied the relationships between protein-protein interactions and human diseases.
LinkedIn